Phase II trial of epidermal growth factor ointment for patients with Erlotinib-related skin effects.
Hwang IG, Kang JH, Oh SY, Lee S, Kim SH, Song KH, Son C, Park MJ, Kang MH, Kim HG, Lee J, Park YS, Sun JM, Kim HJ, Kim CK, Yi SY, Jang JS, Park K, Kim HJ.
Hwang IG, et al. Among authors: kim hg, kim hj, kim sh, kim ck.
Support Care Cancer. 2016 Jan;24(1):301-309. doi: 10.1007/s00520-015-2783-9. Epub 2015 Jun 4.
Support Care Cancer. 2016.
PMID: 26041481
Clinical Trial.